Leirfossvegen, Norway

Peter Molesworth


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Peter Molesworth: Pioneering Nanoparticle Technology

Introduction

Peter Molesworth, an inventive mind located in Leirfossvegen, Norway, has made strides in the field of nanoparticle technology. With a focus on creating novel compounds for therapeutic and diagnostic applications, Molesworth's contributions are both innovative and impactful.

Latest Patents

Molesworth holds a significant patent for "Nanoparticles comprising copolymeric or homopolymeric compounds which comprise cyanoacrylate subunits." This invention details a nanoparticle that consists of copolymeric or homopolymeric compounds based on cyanoacrylate structures. Each R in the formula can be independently chosen from a variety of compounds, including 2-ethylhexyl and 3-heptyl. The nanoparticle is integrated with an active agent and is designed for versatile applications, particularly in the treatment and diagnosis of conditions such as cancer or infections, as well as diagnostic imaging.

Career Highlights

Currently working at Sinteff Tto AS, Peter Molesworth contributes his expertise to a leading technology transfer organization. His work focuses on harnessing advanced materials for healthcare solutions, showcasing his commitment to innovation.

Collaborations

Molesworth collaborates with talented colleagues, including Ruth Schmid and Yrr Mørch. This teamwork fosters an environment of creativity and aims to push the boundaries of nanoparticle applications in medicine and diagnostics.

Conclusion

Peter Molesworth's inventive spirit and dedication to enhancing healthcare technology demonstrate the importance of innovation in the field of nanotechnology. His pioneering work with nanoparticles opens new avenues for therapeutic solutions, positioning him as a notable inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…